Loading provider…
Loading provider…
Neurology Physician in Cincinnati, OH
NPI: 1215190590Primary Practice Location
DRAKE CENTER INC
151 W Galbraith Rd, Cincinnati, OH
Primary Employer
University of Cincinnati Physicians Company, LLC
ucphysicians.com
HQ Phone
Get MD Hani's Phone NumberMobile
Get MD Hani's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
KY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 58 | 83 |
| 2 | 95886Needle measurement and recording of electrical activity of muscles of arm or leg complete study | 22 | 31 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 12 | 13 |
Authors: Tahseen Mozaffar, Mazen Dimachkie, Priya Kishnani, John Day, Kenneth Berger, Ozlem Goker-Alpan
Journal: JAMA Neurol
Emerging toxic neuropathies and myopathies.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Neurol Clin
Publication Date: 2011-07-14
Lead Sponsor: University of Kansas Medical Center
Collaborators: Patient-Centered Outcomes Research Institute
Intervention / Treatment: DRUG: Duloxetine, DRUG: Pregabalin, DRUG: Nortriptyline, DRUG: Mexiletine
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: OTHER: Placebo, DRUG: Pozelimab, DRUG: Cemdisiran, DRUG: Pozelimab + Cemdisiran
Lead Sponsor: Genzyme, a Sanofi Company
Intervention / Treatment: DRUG: Alglucosidase alfa (GZ419829), DRUG: Avalglucosidase alfa (GZ402666)